A detailed history of Paloma Partners Management CO transactions in Pacific Biosciences Of California, Inc. stock. As of the latest transaction made, Paloma Partners Management CO holds 36,901 shares of PACB stock, worth $68,635. This represents 0.0% of its overall portfolio holdings.

Number of Shares
36,901
Holding current value
$68,635
% of portfolio
0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$1.2 - $2.17 $44,281 - $80,075
36,901 New
36,901 $62,000
Q2 2022

Aug 15, 2022

SELL
$4.02 - $10.43 $61,047 - $158,389
-15,186 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$8.43 - $20.9 $128,017 - $317,387
15,186 New
15,186 $138,000
Q4 2021

Feb 14, 2022

SELL
$19.26 - $30.08 $196,009 - $306,124
-10,177 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$24.86 - $35.02 $253,000 - $356,398
10,177 New
10,177 $260,000
Q2 2021

Aug 16, 2021

SELL
$22.3 - $36.02 $343,286 - $554,491
-15,394 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$26.38 - $51.15 $406,093 - $787,403
15,394 New
15,394 $513,000
Q2 2020

Aug 14, 2020

SELL
$2.65 - $4.03 $114,154 - $173,600
-43,077 Closed
0 $0
Q1 2020

May 15, 2020

BUY
$2.36 - $5.26 $101,661 - $226,585
43,077 New
43,077 $132,000
Q4 2019

Feb 14, 2020

SELL
$4.6 - $5.57 $62,762 - $75,997
-13,644 Closed
0 $0
Q3 2019

Nov 14, 2019

SELL
$4.99 - $6.16 $595,232 - $734,795
-119,285 Reduced 89.74%
13,644 $70,000
Q2 2019

Aug 14, 2019

SELL
$5.92 - $7.41 $540,916 - $677,059
-91,371 Reduced 40.74%
132,929 $804,000
Q1 2019

May 15, 2019

BUY
$6.8 - $7.4 $470,560 - $512,080
69,200 Added 44.62%
224,300 $1.62 Million
Q4 2018

Feb 14, 2019

BUY
$3.99 - $7.82 $618,849 - $1.21 Million
155,100 New
155,100 $1.15 Million

Others Institutions Holding PACB

About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.


  • Ticker PACB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 224,840,992
  • Market Cap $418M
  • Description
  • Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...
More about PACB
Track This Portfolio

Track Paloma Partners Management CO Portfolio

Follow Paloma Partners Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Paloma Partners Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Paloma Partners Management CO with notifications on news.